Springbok Analytics has secured U.S. Food and Drug Administration (FDA) clearance for MuscleView, an AI algorithm for analyzing muscle health from MRI scans.
The technology measures musculoskeletal structures from rapid MRI scan protocols and produces 3D visualizations of muscle health, including individual muscle volume, left-right muscle asymmetry, bone volume, and intramuscular fat percentage, the company said.
The AI algorithm was trained and tested on MRI scans generated across varying patients, demographics (including biological sex, age, and ethnicity), scan sites, and MRI parameters, including manufacturer, field strength, series settings/types, matrix size, field of view, and scan resolution, Springbok added.
Springbok partners with professional sports teams for performance, injury recovery, and muscle analysis, as well as supports clinical trials across muscular dystrophy, sarcopenia, and other muscle-related disorders and diseases.
